Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: A retrospective cohort study

Inflammatory Bowel Diseases

Volumn 14, Issue 1, 2008, Pages 13-19

  Flasar, Mark H ^a,b   Johnson, Tamara ^a   Roghmann, Mary Claire ^a   Cross, Raymond K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b 22 South Greene St N3W62 ^*  (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Race; Therapy; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; STEROID;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CROHN DISEASE; DISEASE ASSOCIATION; DRUG USE; ENTERITIS; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ADULT; AFRICAN AMERICANS; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MARYLAND; MIDDLE AGED; STEROIDS;

EID: 38849144620     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20298     Document Type: Article

References (34)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
2. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500-1511.
3. Fiocchi C. Overview of inflammatory bowel disease pathogenesis. London: Churchill Livingston; 2003.
4. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7:260-270.
5. Mayberry J, Mann R. Inflammatory bowel disease in rural sub-Saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion. 1989;44:172-176.
6. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol. 2001;154:328-335.
7. Wright JP, Marks IN, Jameson C, et al. Inflammatory bowel disease in Cape Town, 1975-1980. Part II. Crohn's disease. S Afr Med J. 1983;63:226-229.
8. Wright JP, Froggatt J, O'Keefe EA, et al. The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J. 1986;70:10-15.
9. Wright JP, Marks IN, Jameson C, et al. Inflammatory bowel disease in Cape Town, 1975-1980. Part I. Ulcerative colitis. S Afr Med J. 1983;63:223-226.
10. Mendeloff AI, Monk M, Siegel CI, et al. Some epidemiological features of ulcerative colitis and regional enteritis. A preliminary report. Gastroenterology. 1966;51:748-756.
11. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chron Dis. 1971;24:743-773.
12. Pinchbeck BR, Kirdeikis J, Thomson AB. Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol. 1988;10:505-515.
13. Hiatt RA, Kaufman L. Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med. 1988;149:541-546.
14. Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104-110.
15. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000;46:336-343.
16. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916-924.
17. Sonnenberg A, Wasserman IH. Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology. 1991;101:122-130.
18. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology. 1991;100:143-149.
19. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Digest Dis Sci. 1984;29:913-920.
20. Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940-1948.
21. Ogunbi SO, Ransom JA, Sullivan K, et al. Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998;133:103-107.
22. Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254-2261.
23. Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101:1012-1023.
24. Straus WL, Eisen GM, Sandler RS, et al. Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol. 2000;95:479-483.
25. Goldman CD, Kodner IJ, Fry RD, et al. Clinical and operative experience with non-Caucasian patients with Crohn's disease. Dis Colon Rectum. 1986;29:317-321.
26. Cross RK, Jung C, Wasan S, et al. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12:192-198.
27. Mallinger JB, Fisher SG, Brown T, et al. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatric Serv (Washington, DC). 2006;57:133-136.
28. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19.
29. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260.
30. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994;35:360-362.
31. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
32. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
33. Lichtenstein GR, Abreu MT, Cohen R, et al. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006;130:940-987.
34. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006;130:650-656.